Diabetic cats and pet insurance: insulin or Senvelgo, the remission clause, and the food line most policies refuse

Insulin or a once-daily oral drug: who each label allows

Both oral drugs are sodium-glucose cotransporter 2 (SGLT2) inhibitors. The FDA's owner page, "Two New Drugs to Treat Diabetes in Cats, Is One Right for Your Cat?" (content current as of December 14, 2023), explains that they "are not insulin" and lower blood glucose by sending glucose out through the kidneys. They suit a cat that still makes some insulin of its own, and the FDA lists the cats that cannot take them. The first item on that list decides a great deal: "Cats that have been treated with insulin in the past or are currently on insulin."

The current labels on DailyMed say the same thing in contraindication language. The Bexacat label (effective May 19, 2026) and the Senvelgo label (effective April 1, 2026) each say not to use the drug "in cats with diabetes mellitus who have previously been treated with insulin, who are receiving insulin, or in cats with insulin-dependent diabetes mellitus", and each indication is limited to "otherwise healthy cats with diabetes mellitus not previously treated with insulin." The FDA page adds cats that are lethargic, dehydrated or not eating, cats with diabetic ketoacidosis, cats under the weight the drug requires, and cats with "other health problems, especially disease of the kidneys, liver, or pancreas."

Prices are one online pharmacy's list prices on October 31, 2026, before coupons, tax or shipping; the Senvelgo 30 mL listing showed as out of stock that day. They are cost lines for insurance arithmetic, not doses and not a recommendation of any product or route, which belong to the cat's veterinarian.

The contraindication works like a one-way door. A cat started on insulin, even briefly, has left the oral-drug group for good on the label's words, while a cat started on an oral drug can still be moved to insulin. Remission sharpens this. A cat that goes into remission on insulin and later relapses has been "previously treated with insulin", so its second round of treatment is an insulin claim whatever the owner might prefer.

One clause that troubles other feline claims is not an obstacle here. Bexacat, Senvelgo and ProZinc are all FDA-approved, so a policy that pays only for "approved by the Food and Drug Administration" medication, wording the Spot and Figo samples use, reaches all three. The FIP treatment guide shows what happens when no approved drug exists.

Two first years: the injection route and the oral route

The drug is the visible cost and rarely the largest. Both oral labels put heavy weight on monitoring. The Senvelgo label calls for a physical examination, medical history, CBC, serum chemistry, serum fructosamine and urinalysis with a ketone check before the first dose, then a ketone check "2 to 3 days after initiation of treatment and approximately 7 days after", and a review of glycemic control during the first 4 weeks. The Bexacat label lists blood glucose, fructosamine, serum beta-hydroxybutyrate, feline pancreas-specific lipase, liver values, cholesterol, triglycerides, body weight and clinical signs as things to monitor routinely. Insulin has its own front-loaded schedule: in the ProZinc field study, cats were rechecked at 7, 14, 30 and 45 days after starting.

The table below prices a first year both ways for one illustrative 11 lb cat. Drug, syringe and food lines use the list prices above. Every veterinary line is a round input chosen by the editors to show the structure of the bill, not a fee schedule and not a forecast; clinic prices vary widely by region.

A maintenance year on the same inputs, with four rechecks, comes to $3,298.01 on the oral route ($1,373.16 drug, $800 rechecks at $200, $1,124.85 food) and $3,098.59 on the insulin route ($790.14 insulin, $183.60 syringes, $1,000 rechecks at $250, $1,124.85 food).

On these inputs the two first years land within $11 of each other, and that near-tie is the useful finding, not the exact totals. The oral route spends more on the drug and less on early glucose curves; the insulin route spends less on the drug, needs syringes, and front-loads rechecks. A policy that pays every line barely notices which route the veterinarian chooses. A policy that pays some lines and refuses others notices a great deal, and the line most often refused is not a drug at all. It is the food.

Food is one of the largest lines in both columns: bigger than a year of insulin, and within $250 of a year of the oral drug. Generic arithmetic on any of these figures, such as a different can count or a price change, can be checked with the percentage calculator at CalculatorVillage.

Remission is not a cure, and the sample forms spell out the difference

Remission is common enough to plan around. The Merck Veterinary Manual's owner pages say remission "usually occurs within 3 to 4 months of initiating diet changes and insulin treatment", and Cornell says a cat that has not reached remission within the first six months after diagnosis "will almost certainly require life-long insulin injections." Merck's professional entry, last updated May 2026, says simply: "Remission is possible in cats."

For an insured cat diagnosed after its waiting period, remission is good news with no policy catch. For a cat diagnosed before enrollment, remission raises a hope that the old diabetes might count as cured and become eligible again. The table quotes what each saved sample form says about that route.

Each form is one state's or one species' sample and some are older editions; a cat's own policy and declarations page govern. Embrace, Healthy Paws and Pets Best publish their own curable and incurable wording, quoted on the dog diabetes guide.

Every cured-condition route in these documents is built on a word the veterinary reference declines to use for feline diabetes, and two of them name management as disqualifying. An owner who reads "curable conditions can be covered again" in marketing should read the definition of cured in the policy form before counting on it. AKC's time-based route is the structural exception, and it comes with an inherited-condition exclusion that names diabetes. Before buying any policy for a cat with a diabetes history, ask in writing whether feline diabetes in remission is classed as chronic, and whether routine glucose monitoring counts as treatment.

The general rules behind this table, including how insurers look back through records, are on the pre-existing conditions guide, and getting insurance after a diagnosis covers what a new policy can still pay for when one condition is excluded.

When the diet is the whole treatment: food clauses in a remission year

A cat in remission on a policy that covered its diagnosis still has bills: rechecks, glucose tests, and in many cases the same low-carbohydrate food. Cornell says cats that have achieved remission "should continue to be fed a low-carbohydrate diet and receive close monitoring." Two of the sample food clauses read almost as if they were written for that year, and they point in opposite directions.

The Spot sample pays for "Prescription pet food to treat a covered condition; not for general health maintenance, or prevention", and its exclusions add prescription food "that is used beyond resolution of symptoms for prevention or general health maintenance". A cat in remission has, by definition, resolved symptoms. The AKC sample excludes "All diets, Pet food, whether prescribed or not", then adds: "This does not include a prescription diet used as the sole Treatment of a covered condition." During insulin or oral-drug treatment the diet is not the sole treatment, so the food is excluded; in a diet-only remission it arguably is, which is the one time this clause opens.

Recheck amounts and the can count are editors' inputs; food is the 1800PetMeds list price on October 31, 2026. The AKC reading assumes the insurer accepts the diet as the sole treatment; get that in writing, because the form does not define sole treatment.

MetLife's sample covers food "that can only be purchased from a Veterinary Provider with a prescription from a Veterinarian to treat a covered Illness or Injury", which pays during treatment and leaves the remission year to the insurer's reading of "to treat". Trupanion's 2011 form pays half the food's cost for two months, then offers a premium discount for long-term feeding instead of claims. The full wording of five food clauses, applied to a lifelong thyroid diet, is in the hyperthyroid cat guide, and the same reading carries over to a diabetic diet.

The weight clauses sit one step earlier. The AKC sample excludes treatment for a pet being obese or overweight "if not due to an underlying medical condition", and the 2016 England study below found the odds of diabetes rising with each body-weight band above 4 kg. Weight-loss food before a diagnosis is the owner's cost on these forms; the diabetes that may follow is the claim. The indoor cats guide covers that trade in more detail.

Burmese cats: a breed signal that depends on where the cat comes from

Burmese cats are the breed most often linked with diabetes, and the evidence is real but regional. Cornell's page says "In some countries, Burmese cats appear to have a higher risk of developing diabetes than other breeds, but this may not be true in the United States." Merck's professional entry names five predisposed dog breeds and no cat breed. The large primary-care studies come from the UK, and they are specific about the gap.

For insurance, breed matters in two places. It may be a rating factor in the premium, and it matters to timing, since a cat with a higher expected risk gains more from being enrolled before any sign appears. The 2025 study also found that 10.0 percent of newly diagnosed cats, 36 of 375, died within three days of diagnosis, nearly all by euthanasia, and that 26 of those 36 received no antihyperglycemic medication. The study reports this as a finding about early mortality, not its causes, but it shows how much weight the first month's bill carries.

CoverMyBreed publishes no cat premium anchors and no cat breed pages, so there is no published figure here to compare a Burmese quote with. Bring the live quote and the policy form to the clauses above instead, and read the cats hub for other feline conditions with their own claim arithmetic.

Ketones, a switch to insulin, and a night in hospital

The oral labels build in a hand-off. The Senvelgo label says: "If ketonuria is present, discontinue SENVELGO and promptly treat with insulin, even if blood glucose is normal." The FDA owner page warns that diabetic ketoacidosis and pancreatitis "can happen with or without warning, even if your veterinarian appropriately screened and closely monitored your cat," and that ketoacidosis may happen more often in the first week. On a policy, that moment changes the claim in three ways at once: the drug line moves from an oral solution to insulin and syringes, a hospital stay may appear, and the cat can never return to the oral group.

None of that starts a new condition. Most forms treat related bills as one illness: the AKC sample says a recurring or chronic incident "will be considered one (1) Incident", and the Spot sample counts conditions "related to, secondary, or resultant from" a pre-existing one as part of it. A ketoacidosis stay for a cat whose diabetes is covered is a diabetes claim. Add a $1,500 hospital stay, an editors' input, to the oral-route first year and the total becomes $5,988.01: at a $5,000 annual limit the insurer pays $4,590.41 and the owner $1,397.60, but at a $2,500 limit the owner pays $3,488.01. That is the case for checking limit type before a crisis; per-incident and lifetime limits are compared on the dog diabetes guide.

Switching insurers after a diagnosis is the other way to lose cover. The NAIC model's renewal rule protects a condition on renewal of the same policy; a new insurer looks back through the record and finds the diabetes before its start date. Read how to switch pet insurance before moving a diabetic cat for a lower premium, and remember that kidney disease, which the FDA lists as a reason a cat cannot take the oral drugs, often shares the same years of life; the kidney disease guide prices that claim.

Never tested, in remission, back on insulin: the clause each record meets

Two dates place a cat on this list, its first high glucose reading and the policy's start, and the drug it takes or a second disease can move it. Each answer is a reading of quoted wording, not a prediction of any insurer's decision.